ロード中...
Intraperitoneal chemotherapy in the treatment of gastric cancer peritoneal metastases: an overview of common therapeutic regimens
Peritoneal metastasis (PM) have an incidence of 10–20% in patients with gastric cancer (GC), and even up to 40% in patients with UICC Stage III GC. Due to the aggressive characteristic of adenocarcinoma of the stomach, GC is the third leading cause of cancer deaths worldwide. For GC with PM, the tre...
保存先:
| 出版年: | J Gastrointest Oncol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8100714/ https://ncbi.nlm.nih.gov/pubmed/33968424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-2020-04 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|